Czirr James C 的 Form 4/A 修正申報
修正Galectin Therapeutics IncGALT,2025/12/8 申報
- 申報編號
- 0001493152-25-026587
- 申報時間
- 2025/12/8 13:21 ET
- 交易日
- 2025/12/2-12/3
- 申報延遲
- 6 天
- 10b5-1 計畫
- 沒有勾選
- 原始申報日
- 2025/12/4
這份申報列了 2 筆非衍生性交易。公開市場賣出合計 $92.1 萬。交易後 6 天申報。
這份修正申報取代了 0001493152-25-026204(2025/12/4 申報)。
申報人
一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Czirr James CCIK 0001260641 | 持股 10% 以上大股東 |
| 10X Fund, L.P.CIK 0001453356 | 持股 10% 以上大股東 |
| 10X Capital Management, LLCCIK 0001457247 | 持股 10% 以上大股東 |
非衍生性證券(表 I)
普通股等股票的取得與處分,每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。
- F1
10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- F2
The shares were sold in multiple transactions at prices ranging from $5.40 to $5.50. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The shares were sold in multiple transactions at prices ranging from $5.68 to $5.85. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
表 I 有 1 筆交易的價格引用這則附註。